ingly, the majority of clinical studies examining the effect plantations performed at our institution, we found that the of DA administration following transplantation have administration of dopamine (DA) to the organ donors resulted failed to show a beneficial effect [2] [3] [4] .
in a significant improvement of long-term organ survival of the retrieved kidneys. To study the mechanisms underlying the In searching for an explanation for the protective eforgan protection associated with the administration of DA prior fect of DA administration prior to transplantation, we to transplantation, we questioned whether DA induces the antiwondered how catecholamine pretreatment may protect oxidative enzyme heme oxygenase-1 (HO-1) in cultured endothe organs from the insult of ischemia/reperfusion injury. carbon monoxide [5] . Via this mechanism, HO-1 removes
Results. The presence of DA resulted in a dose-and timedependent up-regulation of HO-1 both on RNA and protein pro-oxidant destabilized heme molecules and generates level, whereas HO-1 was barely detectable under basal condithe antioxidant bilirubin [6] . The induction of HO-1 has tions. RT-PCR indicated the increased presence of HO-1 mesbeen associated with a protective effect in models of senger RNA after 2 hours of incubation with DA, which peaked heme-induced renal failure [7, 8] , and the presence of after 24 hours. The induction of HO-1 antigen was detectable after eight hours, as visualized by Western blot analysis. The HO-1 has been linked to the prevention of chronic alloaddition of the antioxidant agents ascorbic acid and N-acetylgraft rejection and improved xenograft survival in animal cysteine both lead to dose-dependent inhibition of DA-meditransplant models [9, 10] . Conclusion. We conclude that DA induces the expression ful pro-oxidants [11, 12] , we questioned whether DA of the protective enzyme HO-1 in cultured endothelial cells may be capable of inducing HO-1 in endothelial cells.
by an oxidative mechanism. These findings may explain the beneficial effect of DA administration to kidney donors and indicate the potential role of DA in organ preconditioning.
METHODS

Reagents
In a center-based case control study to identify donor-
The following reagents were used: DA (Fresenius, Bad specific determinants affecting outcome in renal transHomburg, Germany); haloperidol (Janssen-Cilag GMBH, plantation, we showed that both donor treatment with Neuss, Germany); ascorbic acid, KCl, ammonium sulfate (all Merck, Darmstadt Germany); hemin, SCH 23390, collagenase V, trypsin, penicillin-streptomycin, HEPES, 
RNA isolation and RT-PCR analysis Cell culture
Total RNA was isolated using TRIZOL reagent according to the manufacturer's instructions. Two microHuman umbilical vein endothelial cells (HUVECs) were prepared from fresh umbilical cords according to grams of total RNA was reverse transcribed into cDNA by oligo-dT and random hexamer priming. Deoxy-oligothe method described by Jaffe et al [13] . Briefly, endothelial cells were isolated from umbilical veins by digestion nucleotide primers were constructed from the published cDNA sequence of HO-1 [14] and GAPDH [15] and with collagenase V for 20 minutes at 37ЊC. Thereafter, the vein was flushed with sterile medium to collect endoresulted in 284 and 268 bp products, respectively. GAPDH controls were performed for all PCRs. The sequences of thelial cells. The culture medium consisted of medium 199 supplemented with 10% FCS, endothelial cell growth the primers were as follows: HO-1 forward, GCT CAA CAT CCA GCT CTT TGA GG; HO-1 reverse, GAC factor, and penicillin-streptomycin. The cells were cultured in 25 or 75 cm 2 flasks coated with 1% gelatin. Con-AAA GTT CAT GGC CCT GGG A; GAPDH forward, GTC TTC ACC ACC ATG GAG AA; and GAPDH fluent cells were harvested with 0.02% EDTA/0.05% trypsin and were subcultured in T25 flasks.
reverse, ATC CAC AGT CTT CTG GGT GG. Amplification of cDNA by PCR was performed by a All experiments were performed with cells from passages two to six. HUVECs were characterized on the modification of the procedure described by Saiki et al [16] One microliter of cDNA, 20 pmol of each primer, basis of positive staining for factor VIII-related antigen and the endothelial marker EN4 (CD31). and 0.5 pmol Taq . The mixture were treated with concentrations of 0.1, 1, 10, 50, and 100 g/mL of DA or norepinephrine in complete culture was heated at 95ЊC for three minutes followed by 27 (HO-1) or 30 (GAPDH) cycles, each consisting of incumedium. Cells were harvested after 16 hours and were assessed for the induction of HO-1 by reverse transcripbation for one minute at 95ЊC, one minute at 62ЊC (HO-1) or 59ЊC (GAPDH), and two minutes at 72ЊC. After tertion-polymerase chain reaction (RT-PCR) and Western blot. Cells were incubated with hemin at 5 mol/L as a mination of the last cycle, the samples were chilled at 4ЊC. Polymerase chain reaction products were separated positive control for HO-1 induction.
The kinetics of DA-mediated HO-1 induction were by electrophoresis on a 1% agarose ethidium bromide gel. Identity of the bands was confirmed by sequencing studied by incubation of HUVECs with medium or medium containing DA (10 g/mL). Cells were harvested on a ABI 310 automatic sequencer. The semiquantitative character of the PCR was ascertained by twofold serial at various time points, and HO-1 induction was assessed by Western blot and RT-PCR.
dilutions of cDNA and controlled for equal expression of the GAPDH PCR product.
Inhibition with DA receptor antagonists
Western blot analysis To study the mechanism of DA-induced HO-1 expression, HUVECs were treated with medium alone or meHuman umbilical vein endothelial cell monolayers were harvested with trypsin EDTA, and subsequently, dium containing DA (10 g/mL) in the presence or absence of increasing doses of either haloperidol (1 to 10 g/mL) the cell pellet was washed twice in ice-cold PBS. Cytoplasmatic proteins were isolated by adding 100 L of lysis or SCH 23390 (0.05 to 50 g/mL). Cells were harvested after 16 hours. Cytoplasmic proteins were isolated and buffer containing 10 mmol/L HEPES, pH 7.9, 10 mmol/L 5 L of 10% Igpal, followed by centrifugation (12,000 g) to remove undissolved debris. Protein concentrations of the supernatants were determined by the Coomassie Blue assay. Twentyfive micrograms of total protein was then separated on 10% SDS-PAGE according to Laemmli [17] and semidry blotted on a PVDF membrane. The membrane was incubated overnight in 5% milk powder in TBS (10 mmol/L Tris-HCl, pH 8.0, 150 mmol/L NaCl) solution. Thereafter, the blot was incubated for one hour with polyclonal rabbit-anti-HO-1 antibodies. After washing, the blot was incubated with HRP conjugated goat-anti-rabbitIgG antibodies for 30 minutes. Antibody binding was visualized by chemiluminescence on a BIO-MAX film.
HUVECs were incubated in the presence (ϩ) or absence (Ϫ) of DA (10 g/mL). Cells were harvested at various time intervals and were assessed for HO-1 by either RT-PCR (A) or Western blot (B).
RESULTS
To examine the effect of DA on the expression of HO-1 by endothelial cells, HUVECs were exposed to level was examined by Western blot (Fig. 2) and showed increasing doses of DA. Hemin at a dose of 5 mol/L a corresponding induction of HO-1 antigen. served as a positive control. mRNA was isolated after
The kinetics of HO-1 up-regulation was determined 16 hours and analyzed for HO-1 expression by semiquanusing DA 10 g/mL and incubation of endothelial cells titative RT-PCR. While HO-1 mRNA was barely detectfor up to 72 hours. Cells were harvested and assessed able under basal conditions, the addition of DA resulted for HO-1 mRNA by RT-PCR and for HO-1 antigen by in a dose-dependent increase in the expression of HO-1
Western blot. As shown in Figure 3A , an increase in clearly detectable at a DA dose of 1 g/mL and with a HO-1 mRNA was detectable after 2 hours and peaked maximum at a DA concentration of 50 g/mL (Fig. 1) . after 6 to 12 hours. HO-1 antigen was detectable after DA concentrations above 100 g/mL resulted in detach-8 hours of incubation with DA and increased for up to ment of the cells. No induction of HO-1 was detected when HUVECs were treated with norepinephrine in a 48 hours as demonstrated by Western blot (Fig. 3B) .
To assess the mechanism of DA-mediated HO-1 uprange of 0.1 to 200 g/mL (data not shown). A twofold serial dilution of cDNA obtained from HUVECs treated regulation, HUVECs were treated with DA in the presence of either the D 1 -receptor antagonist SCH 23390 with DA (10 g/mL) for 16 hours demonstrated a fourfold induction of HO-1 mRNA when compared with or the D 2 -receptor antagonist haloperidol. As shown in Figure 4 , neither increasing doses of SCH 23390 (0.1 to cDNA obtained from cells treated with medium alone (data not shown). The up-regulation of HO-1 on protein 100 g/mL) or haloperidol (0.1 to 10 g/mL) influenced ure 6, the addition of NAC to DA stimulated HUVECs leads to a complete abrogation of HO-1 induction on both protein and mRNA levels.
DISCUSSION
This article demonstrates the induction of the endothelial synthesis of HO-1 by DA in vitro. The DA dose of 1 g/mL, which leads to a powerful induction of both HO-1 RNA and protein in the dose response experiments, is within the upper range of therapeutic steadystate DA levels measured in patients receiving interme- diate dose DA treatment [18, 19] . Our data demonstrate HUVECs were incubated with medium alone, DA (10 g/mL), or DA that DA exerts its effect via an oxidative mechanism. 23390, the induction of both HO-1 mRNA and antigen was inhibited by the addition of the antioxidant vitamin C and completely blocked in the presence of NAC. the DA-mediated up-regulation of HO-1, as detected by Heme oxygenase-1 is induced by a broad spectrum of Western blot analysis. The treatment of HUVECs with oxidative agents [5] . However, to our knowledge, this is either SCH 23390 or haloperidol alone at the maximum the first time a commonly used drug is reported as a doses that did not result in visible cellular toxicity did powerful HO-1 inducer. Furthermore, the association of not influence the expression of HO-1 (data not shown).
donor DA administration with an improved outcome in Since we speculated that DA may exert its effect on renal transplantation underscores the relevance of our the expression of HO-1 by an oxidative mechanism, we findings. examined the effect of the antioxidant agents vitamin C Possible oxidative effects of DA have generated a and N-acetyl-cysteine (NAC) on the expression of HO-1 strong interest in the context of Parkinson's disease and by DA stimulated HUVECs. Both RT-PCR and Westschizophrenia [11, 20] . The auto-oxidation of DA in the ern blot for HO-1 showed that the addition of vitamin C presence of transition metals, for example, iron or copto a fixed dose of DA (10 g/mL) leads to a dose-depenper, leads to the generation of quininones/semiquinones dent although not complete inhibition of the DA-mediated up-regulation of HO-1 (Fig. 5) . As depicted in Figand In our experiments, no up-regulation of HO-1 was obThus, the induction of protective genes such as HO-1 prior to transplantation may provide the organ with a served when HUVECs were treated with norepinephrine. This is in keeping with a weaker toxic effect of resistance to the insult of ischemia/reperfusion and inflammation that results in the improved outcome obnorepinephrine compared with DA [22] .
A recent retrospective study of the cadaveric kidney served after donor DA administration. Since ischemia/ reperfusion is thought to have a strong impact on the transplantations performed at our center showed that the administration of DA to the organ donors prior to transdevelopment of acute and chronic rejection [33] , the reduction of reperfusion injury is a major task in transplantation leads to a significant reduction of acute graft rejection episodes and improvement of long-term surplant medicine. A possible approach is the emerging concept of organ preconditioning [34] . Short periods of vival [1] . Studies on the administration of DA after renal transplantation have either failed to demonstrate an efischemic stress render the organ (for example, the heart) resistant to a subsequent episode of prolonged ischemia. fect [2] [3] [4] or report an adverse association between donor catecholamine use and immediate graft function [23, 24] .
Two distinct phases of protection have been identified. The early phase develops within minutes and has been It has been demonstrated that E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molelinked to the release of adenosine [35] . The second phase is referred to as late preconditioning and takes hours to cule-1 are up-regulated in models of brain injury and cerebral ischemia [25, 26] . The pretreatment of HUVECs become apparent. The generation of reactive oxygen species is an essential component [36] , and the induction of with the inotropes amrinone and DA leads to an inhibition of IL-1␤-mediated up-regulation of adhesion molenuclear factor-B and nitric oxide synthase are both necescules [27] . Thus, possibly the down-regulation of elevated sary for the development of organ protection [37, 38] . adhesion molecules in the transplanted grafts may contribOur results indicate that DA may provide its beneficial ute to the beneficial effect of donor treatment with DA. effect in renal transplantation by pharmacological preHowever, an inhibition of adhesion molecules by cateconditioning with the induction of antioxidative and poscholamines would not explain why the administration of sibly anti-inflammatory genes. The powerful pro-oxida-DA after the transplantation procedure has not proven tive effects may also explain why the administration of to be beneficial. The timely induction of protective genes DA after transplantation is of no benefit or may even prior to the actual ischemia/reperfusion insult may be an be harmful. DA given during the phase of reperfusion alternative explanation. Of these genes, HO-1 is a possible may lead to additional oxidative stress with glutathione candidate. HO-1 is a 32 kD microsomal enzyme that has and NO depletion, resulting in increased damage and been linked to a protective effect in a broad variety of possibly immunogenicity of the transplanted organ. disease models. It catalyzes the conversion of heme to Although of obvious importance, the induction of HO-1 biliverdin, iron, and carbon monoxide (CO) [5] . Via this of course may not be the only beneficial gene induced mechanism, HO-1 degrades destabilized potentially in response to DA-mediated oxidative stress. Further toxic heme molecules and generates biliverdin, which is studies are required to determine whether other candisubsequently converted to the antioxidant bilirubin [6] .
date genes such as superoxide dismutase, glutathione, The iron released during this process is sequestered by nitric oxide synthetase, or catalase are induced by DA. ferritin, which is induced together with HO-1 [28] . An Furthermore, although ample evidence of oxidative meadditional beneficial effect may arise from the synthesis tabolism of cathecholamines in the brain exists [11] , we of CO, which similar to NO is a potent vasodilator [5] .
do not know whether DA administered in vivo is oxiIn vivo models of renal disease have underscored the dized sufficiently to induce the stress necessary for the potential protective role of HO-1. The induction of HO-1 HO-1 induction observed in our in vitro system. Studies confers resistance to the development of renal failure in to examine the induction of HO-1 by DA and its effect glycerol-induced rhabdomyolysis in the rat [7, 8] . Recent on ischemia/reperfusion injury in the presence of the studies have demonstrated that the expression of HO-1 antioxidative armamentarium of the living organism are is linked to an improved outcome both in models of underway. xenotransplantation and chronic rejection [9, 10] . A 
